Loading clinical trials...
Loading clinical trials...
This clinical trial aims to evaluate the safety and efficacy of REGEND001, an autologous basal layer stem cell transplantation therapy, in patients with chronic structural lung disease (bronchiectasis...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Ruijin Hospital
NCT06670937 · Bronchiectasis Adult
NCT06760273 · Bronchiectasis Adult
NCT06393257 · Bronchiectasis Adult
NCT04538859 · Bronchiectasis Adult
NCT07317531 · Bronchiectasis Adult, Expiratory Muscle Training, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions